Home › Asset managers › Compare 2023-2024 › BlackRock vs Charles Schwab
BlackRock 2023-2024 · Charles Schwab 2023-2024 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 11,449 | 10,751 | 620 | 78 | 94.5% | 94.3% |
| Board proposals | 10,771 | 10,162 | 531 | 78 | 95.0% | 94.8% |
| E&S shareholder proposals | 3 | 2 | 1 | 0 | 66.7% | 66.7% |
| Other items | 675 | 587 | 88 | 0 | 87.0% | 87.0% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
620 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | BlackRock | Charles Schwab |
|---|---|---|---|---|---|---|
| VERALTO CORP. | May 21, 2024 | To elect the three Class I directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Francoise Colpron Director Elections |
Board | For | FOR 42 funds |
AGAINST 14 funds |
| VERASTEM INC. | May 23, 2024 | To approve an advisory vote on the compensation of the named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| VERVE THERAPEUTICS INC. | June 6, 2024 | Approval, on an advisory basis, of the compensation paid to our named executive officers. Say-on-Pay |
Board | For | AGAINST 20 funds |
FOR 5 funds |
| VIR BIOTECHNOLOGY INC. | May 29, 2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 31 funds |
AGAINST 8 funds |
| VIRGIN GALACTIC HOLDINGS INC. | June 12, 2024 | Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 19 funds |
AGAINST 3 funds |
| VITESSE ENERGY INC. | May 2, 2024 | Election of Directors: Brian P. Friedman Director Elections |
Board | For | FOR 11 funds |
AGAINST 2 funds |
| VORNADO REALTY TRUST | May 23, 2024 | NON-BINDING, ADVISORY RESOLUTION ON EXECUTIVE COMPENSATION. Say-on-Pay |
Board | For | FOR 39 funds |
AGAINST 14 funds |
| W.W. GRAINGER INC. | April 24, 2024 | Election of Directors: Beatriz R. Perez Director Elections |
Board | For | FOR 54 funds |
AGAINST 13 funds |
| WALGREENS BOOTS ALLIANCE INC. | January 25, 2024 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 55 funds |
AGAINST 15 funds |
| WAVE LIFE SCIENCES LTD. | August 1, 2023 | To authorize the Board of Directors to allot and issue Ordinary Shares of Wave Life Sciences Ltd. Capital Structure |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| WEST BANCORPORATION INC. | April 25, 2024 | To approve an amendment to the West Bancorporation, Inc. 2021 Equity Incentive Plan. Compensation |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| WESTWOOD HOLDINGS GROUP INC. | May 1, 2024 | To approve the Tenth Amended and Restated Westwood Holdings Group, Inc. Stock Incentive Plan. Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| WORKIVA INC. | May 30, 2024 | Election of Directors: Robert H. Herz Director Elections |
Board | For | FOR 20 funds |
WITHHOLD 6 funds |
| XBIOTECH INC. | June 20, 2024 | To ratify the selection by the Audit Committee of the Board of Directors of Whitley Penn LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024. Audit-related |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| XCEL ENERGY INC. | May 22, 2024 | Approval of Xcel Energy Inc.'s executive compensation in an advisory vote (say on pay vote) Say-on-Pay |
Board | For | FOR 58 funds |
AGAINST 15 funds |
| XERIS BIOPHARMA HOLDINGS INC. | June 5, 2024 | Election of Directors: Marla S. Persky Director Elections |
Board | For | WITHHOLD 9 funds |
FOR 2 funds |
| XP INC. | October 6, 2023 | APPROVAL AND RATIFICATION OF THE REAPPOINTMENT OF EACH OF GUILHERME DIAS FERNANDES BENCHIMOL, BRUNO CONSTANTINO ALEXANDRE DOS SANTOS, BERNARDO AMARAL BOTELHO, FABRICIO CUNHA DE ALMEIDA, MARTIN EMILIANO ESCOBARI LIFCHITZ, GABRIEL KLAS DA ROCHA LEAL, LUIZ FELIPE AMARAL CALABRO AND CRISTIANA PEREIRA AS DIRECTORS. Director Elections |
Board | For | FOR 24 funds |
AGAINST 7 funds |
| XP INC. | May 24, 2024 | Approval of the reappointment of Martin Emiliano Escobari Lifchitz as an independent director. Director Elections |
Board | For | FOR 26 funds |
AGAINST 6 funds |
| ZENTALIS PHARMACEUTICALS INC. | June 21, 2024 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 19 funds |
AGAINST 5 funds |
| ZIMMER BIOMET HOLDINGS INC. | May 10, 2024 | Election of Directors: Sreelakshmi Kolli Director Elections |
Board | For | FOR 41 funds |
AGAINST 15 funds |
← Previous Page 7 of 7
How items are matched and positions counted: see the comparison table and the methodology. Built October 18, 2026 from SEC Form N-PX filings.